PDRN Injections Under the Eyes: What to Know and Expect

If you are offered “PDRN under the eyes”, the key question is not how fashionable the name sounds, but which exact product will be injected and what problem it is supposed to address. Injections of DNA-fragment-based products are being studied mainly for skin quality and fine wrinkles around the eyes. They are not a universal solution for a pronounced tear trough, genuine eye bags, excess skin or dark circles caused by allergies or pigmentation. Findings are promising but still limited; the eye area calls for careful assessment by a suitably qualified medical professional.

It is perfectly reasonable to decide that a barely perceptible change is not worth needles and several days of uncertainty about your appearance. If you are considering the method, however, understand the difference between PN and PDRN, the likely results, discomfort, reasons to postpone, risks and what to ask before consenting.

Are PDRN and polynucleotides the same injections?

PDRN means polydeoxyribonucleotide, material made from chains of DNA fragments. PN means polynucleotides, generally longer chains; aesthetic advertising often conflates the terms. Reviews note that no molecular-weight boundary is universally accepted by all manufacturers. “Salmon DNA” as a marketing phrase is no substitute for the product's ingredients, purification, concentration, additives and legal status.

This distinction matters particularly below the eyes. Some research examines injected PN products; other research concerns PDRN, PN mixed with hyaluronic acid, or topical application combined with device treatments. Results from one route cannot automatically be transferred to another. A PDRN cream is not equivalent to a sterile injectable; a product intended only for topical use must never be injected.

Ask for the exact brand, manufacturer, complete formulation, officially labelled purpose, local registration and permitted use in the country where treatment will occur, batch number and expiry date. If use outside the stated indication is proposed, the clinician should explain that separately and obtain informed consent. Do not accept “all PDRN is identical; the packaging does not matter”. Approval in one country does not automatically confer permission to use it in Armenia.

Which under-eye changes are worth discussing—and which are not?

Thin skin, the orbicularis oculi muscle, superficial vessels, fat pads and the bony contour lie close together below the eyelid. Similar-looking “tiredness” may have different causes and need different solutions. A small improvement in elasticity or surface texture may be visible if the main problem is superficial. But injections aimed at skin quality cannot be expected to correct an anatomical hollow or chronic puffiness, even if technically performed well.

What you see	Possible explanation	Does PN/PDRN make sense?
Fine dry creasing beneath the eye	Changed texture and superficial fine lines	It may be discussed for potentially modest improvement in skin quality with an appropriately selected product
Crow's feet when smiling	Active facial muscles alongside skin characteristics	Skin quality might change, but the muscle cause will remain; botulinum toxin addresses a different issue
Deep tear trough and shadow	Anatomical volume deficit or tissue transition	Do not expect major volume replacement from a skin-quality product; assess alternatives individually
Dark circles without creases	Pigment, visible vessels, allergy, inherited traits or shadows	Investigate the cause first; PN/PDRN is not a proven universal lightening treatment
Eye bags and recurring puffiness	Fat pads, a tendency to retain fluid, sometimes medical causes	Injections may not help and can temporarily worsen swelling

Persistent or one-sided changes, itching, allergic signs and eye pain warrant a separate medical discussion. Cleveland Clinic describes many causes of dark circles, including eczema-related problems, anatomy and pigmentation. When the concern is a symptom of disease rather than cosmetic texture, selecting an injectable must not replace diagnosis.

How persuasive is the evidence specifically around the eyes?

In a 2022 randomised trial of 27 participants, a PN product was injected on one side of the periorbital area and non-cross-linked hyaluronic acid on the other, over three treatments spaced two weeks apart. PN performed better on some measures of texture, hydration and elasticity, but overall aesthetic ratings were not significantly different. Both sides received active injections, with no untreated control, and the study received funding from a manufacturer of the PN product. This small study of a particular PN product does not prove that all PDRN products outperform hyaluronic acid or no procedure.

A systematic review published in a 2025 journal issue, searching English-language research from January 2010 through January 2024, included nine studies of aesthetic polynucleotide use. They were generally of low or moderate quality, with different body areas, treatment schedules and outcome measures. A narrower systematic review of injectable PN around the eyes, published in October 2026, included six studies and 350 people. It reported encouraging short-term changes in crow's feet and skin-quality measures, but no included trial followed people beyond six months. Most participants were Korean or Thai; the findings should not yet be generalised to every skin phototype and age group.

This does not prove the procedure fails. It means that promises of “lifelong regeneration” and precise percentages of personal improvement are not justified. Even when a study group improves on average, an individual woman may see only a modest change or none at all. The manufacturer, formulation, injection depth, baseline skin and other treatments matter; the term “bioregeneration” alone does not measure a benefit.

What usually happens during injections, and will they hurt?

First, a medical practitioner assesses skin, the causes of wrinkles or shadows, previous injections, medication, allergies and swelling tendency. After explaining the particular product and obtaining consent, they clean the skin and may use appropriate approved local anaesthesia. They then inject using a technique chosen for that patient. Multiple small injection points are often discussed around the eyes, but the number, depth and location depend on the product and anatomy; this is not a technique to reproduce yourself.

You may feel the needle, stinging or pressure, particularly where the skin is thin. Numbing cream may reduce discomfort but cannot guarantee a painless experience. A low pain threshold is a legitimate subject to raise. Ask how you can stop the procedure if it hurts, without embarrassment or feeling you are “interrupting the doctor”. Do not ask for a larger amount to guarantee a result: extra volume in a swelling-prone area does not necessarily improve appearance.

The practitioner's training matters. Ideally, injections should be performed by a medical professional skilled in periorbital anatomy, sterile technique, recognition of vascular, allergic and infectious complications, and arranging emergency help. “Risk-free because it's natural” is incompatible with an invasive procedure. Before paying, ask who will be reachable afterwards and who will arrange urgent referral if warning symptoms appear.

What will your face look like afterwards—medically and socially?

In the first hours, tiny puncture marks and bumps, redness, tenderness or modest swelling may be visible. Some people bruise, especially with thin skin or an increased tendency to bleed. Small PN studies mostly recorded brief local reactions; they cannot guarantee every patient that “nobody will notice tomorrow”. Appearance depends on the product, technique and individual response.

You may be well enough to work at a computer the next day yet feel uncomfortable on a video call without makeup. By day three one woman may have almost no marks while another's bruise looks more obvious—an illustration of variability, not a promised timeline. If discretion is important at a wedding, interview or shoot, avoid your first injection immediately before the event. Discuss sufficient time for your own bruising and swelling risk.

Afterwards you are usually advised not to rub injection sites, to keep the skin clean and to follow individual aftercare instructions. Return to makeup, vigorous exercise, saunas and active cosmetic ingredients depends on your skin and exact product. Do not apply irritating acids to injured skin or massage the bumps without the clinician's direction. Sun protection remains valuable regardless of injections: it can help prevent worsening pigmentation, but it will not fix an injection complication.

Any improvement in skin quality should be assessed after same-day puffiness subsides, with comparable photographs several weeks later, rather than by swelling itself. Research has used different schedules, including courses of injections, but there is no universally necessary number of sessions or confirmed duration of benefit for all PN/PDRN formulations. Our separate article about PDRN under-eye before-and-after photographs explains how to judge whether a pictured change is relevant to your goal.

When should injections be postponed, and which symptoms must not be ignored?

Active infection of the skin or tissue around the eye, a herpes outbreak or marked irritation at the injection site are reasons to postpone elective treatment until the condition is assessed and resolved. Tell your clinician about known fish allergy, particularly if the material comes from fish; do not proceed without close review of the ingredients and manufacturer's guidance. Also disclose previous allergic reactions to injectables and anaesthetics.

Reliable information about cosmetic PN/PDRN injections during pregnancy and breastfeeding is insufficient, so postponing elective treatment is prudent. Bleeding disorders, anticoagulants or other medicines, immune disorders, active inflammatory disease and a tendency towards pronounced swelling require individual medical assessment. Never stop prescribed medication yourself for a cosmetic session: any change must be decided by the prescriber.

After injection	What to do
Mild local tenderness or a stable bruise	Follow your personal instructions and contact the practitioner if the course is unclear
Increasing redness, warmth, painful swelling, pus or fever	Seek prompt medical assessment for possible infection
Unusually severe pain, sudden blanching or mottled skin discolouration	Seek emergency medical care immediately
Sudden visual deterioration, double vision, severe eye pain or neurological symptoms	Get emergency help immediately; do not wait for a message reply or the next appointment
Difficulty breathing, or swelling of the tongue or throat	Call emergency services immediately: a severe allergic reaction is possible

Serious vascular complications are well documented for dermal fillers, especially after accidental entry into a blood vessel. It would be wrong to assign the same event rate to pure PDRN: a reliable rate has not been established. But alarming symptoms after injection of an incompletely identified product near the eye must never be ignored, especially where it contains hyaluronic acid or belongs to the filler category. The absence of serious events in small studies does not rule out rare complications.

How do you compare alternatives without buying unnecessary treatment?

Match the approach to the cause of your concern. For dryness and a damaged skin barrier, gentle home skin care and sun protection may be the first step. Allergic inflammation or eczema calls for appropriate medical management. If lines are primarily caused by facial movement, a clinician may discuss botulinum toxin, which works differently and has different contraindications and risks. For an anatomical hollow, volume correction may be discussed or rejected because of swelling concerns; fillers in this region have their own serious vascular risks.

Prominent bags or excess skin may call for an eyelid specialist rather than another “regeneration” course. Pigmentation must be identified by type: melanin-related brown marks and bluish visible vessels are not treated identically. Avoid scheduling several unfamiliar interventions together “to boost results”: it becomes harder to identify the cause of a reaction, and added benefit of combinations is not always scientifically established.

To understand total cost, request a written plan covering the exact product and volume, examination before injection, proposed number of visits and reassessment criteria, anaesthesia, follow-up, the cost of handling a reaction and any exclusions. Local prices and availability of particular products are not claimed here because independent verification would be needed. You can take time to think and decline a pressured package.

Six questions before consenting

What is causing what I see: thin skin, active expression, pigmentation, hollowness, swelling or a combination?
What is the exact brand and full composition, and which documents establish its intended use, provenance and permission for this area?
What research covers this exact formulation and injection route, where does the evidence end, and what outcome is realistic?
Who will inject it, what training do they have in anatomy around the eyes, and what will happen if I develop complications that evening or the next day?
How will results be assessed without confusing transient swelling with improvement, and when is the decision made to continue a course?
Can I choose not to have the treatment, or choose an alternative, while still receiving an independent medical assessment?

Informed consent is more than paperwork before a needle. You deserve clear answers about limitations, discomfort, recovery and safety. If someone promises to “remove bags completely” without examining you, conceals the packaging or says there are no risks, getting another opinion is sensible. The eye area is too individual for a decision based on one popular ingredient name.

Frequently asked questions

Can I inject PDRN from my home skin-care serum beneath the eyes?

No. A cosmetic serum is made for external use; its sterility, formulation and intended purpose are not equivalent to those required for an injectable medical device or drug. Self-injecting near the eyes is dangerous.

Does everyone need an allergy skin test before PN/PDRN?

There is no single universal testing scheme for every product. Discuss known allergies, the source material, ingredients and the exact manufacturer's instructions with your clinician. A do-it-yourself test does not guarantee safety.

Can PDRN be combined immediately with a filler or laser?

Such combinations should not be prescribed automatically. A clinician must explain separate indications, sequence, recovery periods and restrictions for each intervention. Simultaneous treatments also make it harder to judge benefits and identify the cause of a reaction.

What if firm nodules remain after treatment?

Do not try to squeeze or dissolve them yourself. Contact the medical practitioner for an examination. If severe pain, colour change, increasing inflammation or visual symptoms develop, seek care urgently as described above.